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Abstract
The protein encoded by the vaccinia virus F13L open reading frame is required for the wrapping of intracellular mature virions by
cisternae derived from trans-Golgi or endosomal membranes and is an abundant, palmitylated component of the outer membrane of
extracellular virions. To study the topology of the F13L protein, we constructed recombinant vaccinia viruses and plasmids that express the
F13L protein with an N- or C-terminal HA epitope tag. The recombinant viruses formed normal-size plaques and the tagged proteins were
incorporated into the two outer membranes of intracellular enveloped virions (IEV), indicating that the epitope-tagged proteins were
functional. By selective permeabilization of the plasma membrane of infected or transfected cells, we demonstrated that the N- and C-termini
of the F13L proteins in the outer IEV membrane, as well as cellular membranes, were oriented toward the cytoplasm. After fusion of the
outer viral membrane with the plasma membrane, externalized virions retain the inner of the two IEV membranes. The N- and C-termini
of the F13L protein were exposed on the inner surface of this extracellular viral membrane, consistent with the accepted model of biogenesis
of the IEV membrane by a wrapping process. Using a coupled in vitro transcription and translation system modified by the addition of
microsomes, we determined that the F13L protein associated posttranslationally with membranes. The N- and C-termini were susceptible
to protease digestion and the protein could be extracted with sodium carbonate, consistent with a peripheral mode of association.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
Poxviruses are large, enveloped DNA viruses that repli-
cate in the cytoplasm of host cells (Moss, 2001). The as-
sembly of vaccinia virus, the most intensively studied mem-
ber of the family, begins with the formation of crescent-
shaped membranes that can be visualized by electron
microscopy (Dales and Siminovitch, 1961). The crescents
enlarge into spheres called immature virions (IV), which
then undergo internal condensation to form brick-shaped
infectious intracellular mature virions (IMV). Some of the
IMV are wrapped by trans-Golgi or endosomal cisternae to
form intracellular enveloped virions (IEV) containing two
additional membranes (Hiller and Weber, 1985; Schmelz et
al., 1994; Tooze et al., 1993). The IEV are transported along
microtubules to the periphery where fusion between the
outer IEV membrane and the plasma membrane occurs,
followed by the formation of motile actin tails that facilitate
spread of cell-associated enveloped virion (CEV) to neigh-
boring cells (Geada et al., 2001; Hollinshead et al., 2001;
Rietdorf et al., 2001; Ward and Moss, 2001a,b). Some
virions, known as extracellular enveloped virions (EEV),
are released into the medium and mediate long-range spread
(Payne, 1980).
Of the seven proteins that have been identified as con-
stituents of the IEV membrane, the ones encoded by the
F13L and B5R open reading frames (ORFs) are essential for
wrapping of the IMV (Blasco and Moss, 1991; Engelstad
and Smith, 1993; Wolffe et al., 1993). The F13L product,
called p37K for its apparent mass determined by SDS–
polyacrylamide gel electrophoresis (PAGE), is a 372 amino
acid nonglycosylated polypeptide that is palmitylated at
cysteine residues 185 and 186 and localizes in the Golgi
network (Grosenbach et al., 1997; Hiller and Weber, 1985;
Hirt et al., 1986; Payne, 1978; Schmelz et al., 1994). Palmi-
tylation is required for membrane association, proper intra-
cellular targeting, and virion wrapping (Borrego et al.,
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1999; Grosenbach and Hruby, 1998; Husain and Moss,
2001; Schmutz et al., 1995). In addition, the F13L protein
contains a variant of the HKD motif that is conserved in
members of the phospholipase superfamily and is required
for membrane wrapping of IMV (Husain and Moss, 2001;
Roper and Moss, 1999; Sung et al., 1997). Based largely on
the resistance of intact EEV to protease digestion and its
unreactivity to an F13L monoclonal antibody (mAb), it was
suggested that the F13L protein is located on the inner side
of the extracellular viral membrane (Roos et al., 1996;
Schmutz et al., 1995). Here, by constructing recombinant
vaccinia viruses and expression plasmids with an epitope
tag on the N- or C-terminus of the F13L protein, we have
determined its topology on intracellular and extracellular
viral and cellular membranes. Further experiments with an
in vitro system provided evidence for the posttranslational
insertion of the F13L protein into membranes.
Results
Construction of recombinant vaccinia viruses that express
functional epitope-tagged F13L protein
We constructed two recombinant viruses, vF13L-HAN
and vF13L-HAC, in which DNA encoding a short epitope
tag derived from the influenza virus hemagglutinin (HA)
was appended to either the N- or the C-terminus of the F13L
ORF, respectively. An F13L deletion mutant of vaccinia
virus strain Western Reserve (WR) that makes tiny plaques
(Blasco and Moss, 1991) was used as the parental virus and
the epitope-tagged F13L ORF was introduced into the de-
letion site by homologous recombination. The recombinant
viruses were recognized by their large plaque size and the
presence of the F13L ORF was confirmed by polymerase
chain reaction (PCR). The plaques formed by vF13L-HAN
and vF13L-HAC recombinant viruses were similar to those
of wild-type strain WR virus (Fig. 1A), indicating that the
epitope tags did not interfere with virus formation or spread.
Expression of the HA-tagged F13L proteins was demon-
strated by SDS–PAGE followed by Western blotting using
an anti-HA monoclonal antibody. Bands of 37 kDa, corre-
sponding to the known mobility of the F13L protein, were
detected by analysis of lysates from cells infected with
vF13L-HAN or vF13L-HAC virus (Fig. 1B).
Laser scanning confocal microscopy was used to locate
the epitope-tagged F13L protein in infected cells. Cells
infected with vF13L-HAN or vF13L-HAC were fixed, per-
meabilized with Triton X-100, and then stained with a
mouse mAb to the HA tag and with Alexa 568 conjugated
phalloidin to visualize actin polymers. In addition to intense
staining of the juxtanuclear Golgi region by the HA mAb,
Fig. 1. Plaque formation and expression of F13L epitope-tagged protein by recombinant vaccinia viruses. (A) Plaque phenotypes. BSC-1 cells were infected
with standard vaccinia virus (WR) or recombinant vF13L-HAN or vF13L-HAC and overlaid with medium containing methylcellulose. After 48 h, the plaques
were visualized by staining with crystal violet. (B) Western blot of epitope-tagged proteins. HeLa cells were mock-infected or infected with vF13L-HAN or
vF13L-HAC viruses. After 24 h, the cells were lysed and the proteins were resolved on a 12% polyacrylamide SDS gel, transferred to a nitrocellulose
membrane, and probed with anti-HA mAb. An autoradiograph is shown with the positions and masses in kilodaltons of markers on the left.
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punctate fluorescence was discerned in the periphery (Fig.
2). Many of these fluorescent spots were at the tips of actin
tails, identifying them as CEV. Those spots that did not
localize with actin tails may represent IEV or vesicles con-
taining viral proteins. As will be shown later, IEV were
distinguished from vesicles by DNA staining.
Topology of the N- and C-termini of the F13L protein in
viral membranes
Having shown that the epitope-tagged F13L proteins
were expressed, incorporated into viral membranes, and
functioning normally as determined by the large plaque size
of the recombinant viruses, more detailed studies were car-
ried out. The epitope tags were used to investigate the
membrane orientation of the N- and C-termini of the F13L
protein. Cells infected with vF13L-HAN or vF13L-HAC
were fixed and either the plasma membrane was selectively
permeabilized with digitonin (Plutner et al., 1992) or mem-
branes were nonselectively permeabilized with Triton
X-100. The cells were then stained with a mouse mAb to
HA and as a control with a rat mAb to the luminal domain
of the B5R protein. The HA juxtanuclear, punctate, and
plasma membrane staining of digitonin-treated cells that
had been infected with vF13L-HAN or vF13L-HAC (Fig. 3)
indicated that both ends of the F13L protein faced the
cytoplasm. The intense staining of the vertices of the cells
was consistent with the collection of IEV following micro-
tubular transport (Ward and Moss, 2001b). Very similar
staining occurred when the cells were permeabilized with
Triton X-100 (Fig. 3). In contrast, the mAb to the luminal
domain of B5R only stained the plasma membrane of dig-
itonin-treated cells, confirming the selectivity of the perme-
abilization procedure (Fig. 3). Treatment with Triton X-100
was required to stain intracellular structures with the B5R
mAb (Fig. 3).
As mentioned, both vesicles and IEV could appear as
punctate structures when stained with F13L antibody. To
distinguish IEV, the DNA in the digitonin-permeabilized
cells was stained with 46-diamidino-2-phenylindole
(DAPI). IEV in the periphery of the cell were identified by
punctate DAPI fluorescence that colocalized with F13L
(Fig. 4). F13L-staining and DAPI-non-staining punctate
structures may represent endosomal or other vesicles; F13L-
non-staining and DAPI-staining punctate structures may
represent IMV. The cells were also stained with the mAb to
B5R to distinguish the cell-surface CEV from the intracel-
lular IEV (not shown).
The IEV membrane is composed of two layers that
cannot be resolved by confocal microscopy. Therefore ad-
ditional studies were carried out in which cells infected with
vF13L-HAN or vF13L-HAC were analyzed by immunoelec-
tron microscopy. Gold grains, representing the HA mAb,
were detected on both IEV membranes (Fig. 5A and B), but
not on IMV or in cells infected with vaccinia virus lacking
the epitope tag on the F13L protein (not shown).
CEV, which contain only the inner of the two IEV
membranes, were examined by immunoelectron micros-
copy to determine the orientation of the N- and C-terminal
ends of the F13L protein. The clearest results were obtained
by immunostaining with mAb and Protein A gold prior to
fixation and sectioning. Under these conditions, only CEV
with defects in their membrane were stained and the gold
grains clearly lined the inner side of the CEV membrane
(Fig. 5C and D).
Thus, by confocal microscopy, we demonstrated that the
F13L protein on the outer IEV membrane has N- and C-
termini that face the cytoplasm and by immunoelectron
microscopy we showed that the ends of the F13L protein of
the inner membrane face the enclosed virion.
Topology of the N- and C-termini of the F13L protein in
cellular membranes
The above results were consistent with the formation of
the IEV membrane by wrapping of IMV with cisternal
vesicles that have the F13L protein on their cytoplasmic
surface. Our previous studies indicated that the F13L pro-
tein associates primarily with the Golgi complex and endo-
somes when expressed in uninfected cells and suggested
that these cisternae are precursors of the wrapping mem-
branes in infected cells (Husain and Moss, 2001). To deter-
mine the topology of the F13L protein in these structures,
we constructed plasmids in which a cytomegalovirus pro-
moter regulated F13L-HAN and F13L-HAC expression. Fol-
lowing transfection, unpermeabilized cells or cells perme-
abilized with digitonin or Triton X-100 were stained with
anti-HA mAb. No staining of unpermeabilized cells was
detected (Fig. 6). Staining was similar, however, when the
cells were permeabilized by either method (Fig. 6), indicat-
ing that the F13L protein was on the cytoplasmic face of
membranes when synthesized in the absence of other viral
proteins.
In vitro synthesis and membrane association of
F13L-HAN and F13L-HAC polypeptides
Although palmitylation of the F13L protein is required
for its association with membranes (Borrego et al., 1999;
Grosenbach and Hruby, 1998; Husain and Moss, 2001;
Schmutz et al., 1995), it had been suggested that two small
hydrophobic regions near the center of the protein might be
membrane anchors (Hirt et al., 1986). To further study the
association of F13L with membranes, we constructed plas-
mids containing the F13L-HAN or F13L-HAC ORF regu-
lated by a bacteriophage T7 promoter for use as templates in
a coupled transcription and translation system containing
canine pancreatic microsomes. Sedimentation through a su-
crose cushion and SDS–PAGE were used to assess mem-
brane-association. Identical results were obtained with the
N- and C-tagged protein so only results with the former are
shown here. In the absence of microsomes, a band with an
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estimated molecular mass of approximately 37 kDa was
detected exclusively in the supernatant fraction when the
template was either F13L-HAN (Fig. 7A) or F13L-HAC (not
shown). Upon inclusion of microsomes in the reaction, the
37-kDa band was also detected in the membrane pellet
fraction (Fig. 7A). To investigate the topology of the F13L
protein, the supernatant and pellets were treated with pro-
tease under conditions in which only cytoplamically ori-
ented proteins are susceptible (Betakova et al., 1999; da
Fonseca et al., 2000). Both ends of the F13L protein were
digested, as no protein bands were detected in either the
supernatant or the pellet fraction (Fig. 7A and data not
shown).
Treatment with sodium carbonate was carried out under
Fig. 2. Detection of epitope-tagged F13L proteins on CEV with actin tails. HeLa cells were infected with either vF13L-HAC or vF13L-HAN. At 20 h after
infection, the cells were fixed and permeabilized with Triton X-100 and then stained with anti-HA mAb followed by fluorescein isothiocyanate (FITC)
conjugated anti-mouse immunoglobulin (green) and with Alexa 568-conjugated phalloidin (red). The cells were examined by confocal microscopy.
Arrowheads point to examples of particles that stained with the anti-HA mAb and are associated with actin tails that stained with phalloidin. Bars, 10 m.
Fig. 4. Colocalization of epitope-tagged F13L protein and DNA in IEV. HeLa cells were infected with vF13L-HAN or vF13L-HAC for 20 h at 37°C, fixed,
permeabilized for 5 min with 25 g of digitonin per milliliter at 0°C, and then stained with anti-HA mAb followed by fluorescein isothiocyanate (FITC)
conjugated anti-mouse immunoglobulin (green). The cells were then washed, fixed again, permeabilized with Triton-X100, stained for DNA with DAPI for
20 min at room temperature (blue), and analyzed by confocal microscopy. Arrowheads point to representative IEV particles that stain for F13L and DNA.
Bars, 10 m.
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Fig. 3. Localization of epitope-tagged F13L and B5R proteins in infected cells permeabilized with digitonin or Triton X-100. HeLa cells were infected with
vF13L-HAN or vF13L-HAC for 20 h at 37°C, fixed, permeabilized for 5 min with 0.2% Triton X-100 at room temperature or 25 g of digitonin per milliliter
at 0°C, and then stained with anti-HA mAb followed by rhodamine red conjugated anti-mouse Ig (red). The cells were then stained with an anti-B5R rat mAb
followed by FITC-conjugated anti-rat Ig (green) and analyzed by confocal microscopy. Bars, 10 m.
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conditions in which proteins containing a transmembrane
domain remain bound (Betakova et al., 1999; da Fonseca et
al., 2000; Howell and Palade, 1982). The complete extrac-
tion of the F13L protein with sodium carbonate indicated
that it does not traverse the membrane (Fig. 7B). This result
differed from that previously described for extraction of
EEV with sodium carbonate (Schmutz et al., 1995), possi-
bly because in that study the released F13L protein was
trapped between the EEV and IMV membranes or the F13L
protein was associated with other viral proteins.
Previous studies indicated that the F13L protein parti-
tions in Triton X-114, only when palymitylated (Schmutz et
al., 1995). A similar approach was used to analyze the
hydrophobicity of the F13L polypeptide synthesized in the
presence and absence of microsomes. After temperature-
induced phase separation, proteins from the aqueous and
detergent phases were resolved by SDS–PAGE. In the ab-
sence of microsomes, the F13L protein was mostly in the
aqueous phase (Fig. 7C). A larger fraction was in the de-
tergent phase when microsomes were present (Fig. 7C),
suggesting that palymitylation of F13L occurred under these
conditions, albeit incompletely. The ratios of F13L in the
aqueous and detergent phases were 3:1 and 10:1 in the
presence and absence of microsomes, respectively.
The peripheral association of the F13L protein with
membranes suggested that it occurs posttranslationally. This
was assessed using cycloheximide, an inhibitor of protein
synthesis. When added at the start of the transcription–
translation reaction, the drug entirely prevented synthesis of
the F13L protein, indicating its activity. When cyclohexi-
mide was added after the transcription–translation reaction,
but before addition of microsomes, membrane association
was detected indicating that it can occur posttranslationally
(Fig. 7D).
Fig. 5. Immunoelectron microscopy of epitope-tagged F13L protein in IEV and CEV membranes. HeLa cells were infected with vF13L-HAN (A, C) or
vF13L-HAC (B, D) for 20 h at 37°C. After fixation and cryosectioning, the cells were stained with anti-HA mAb followed by Protein A conjugated to gold
grains (A, B). Unfixed and unpermeabilized cells were stained with anti-HA mAb followed by Protein A conjugated to gold grains (C, D). Subsequently,
the cells were fixed and cryosectioned.
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Discussion
To investigate the topology of the F13L protein, the
major membrane component of the extracellular virion en-
velope, we constructed recombinant viruses that express the
F13L protein with an HA epitope tag at the N- or C-
terminus. The use of these constructs distinguished our
study from previous ones, which depended on a mAb to an
unmapped epitope on the F13L protein. Synthesis and viral
membrane-association of the epitope-tagged proteins were
demonstrated with an HA-specific mAb by Western blotting
and by fluorescence and electron microscopy. Virus plaque
size and replication were unaffected, indicating that the
epitope tags did not compromise the function of the F13L
protein. In contrast, deletion or certain mutations of the
F13L gene cause a severe reduction in virus transmission
and plaque size (Blasco and Moss, 1991; Roper and Moss,
1999).
Fig. 7. Membrane association of in vitro synthesized F13L-HAN pro-
tein. Proteins were synthesized using a reticulocyte transcription and
translation system in the presence of [35S]methionine with or without
added microsomes. Supernatant (S) and pellet (P) fractions were ob-
tained by centrifugation through a sucrose cushion and analyzed by
SDS–PAGE and autoradiography. (A) Susceptibility to protease di-
gestion. Supernatant and pellet fractions were incubated with pronase
for 30 min on ice before analysis. (B) Extraction of membrane-bound
F13L protein with sodium carbonate. All reactions contained the DNA
template. The pelleted microsomes were resuspended in NTE buffer or 0.1
M sodium carbonate, pH 11.0 and incubated on ice for 20 min before
repelleting and analysis. (C) Phase separation of proteins. At the end of the
reaction, the mixture was mixed with buffer containing 1% Triton X-114
and aqueous and detergent phases were obtained by lowering the temper-
ature. Samples of the total reaction mixture (T) and aqueous (A) and
detergent (D) phases were analyzed. (D) Posttranslational association of
F13L protein with membranes. Cycloheximide and microsomes were
added to a reaction at 0 time (0) or cycloheximide and microsomes were
added to a reaction after 60 min incubation (60). The latter samples (right
two lanes) were incubated for an additional 30 min before analysis.
Fig. 6. Reactivity of epitope-tagged F13L protein in transfected uninfected
cells permeabilized with digitonin. HeLa cells were transfected with plas-
mids pF13L-HAN or pF13L-HAC for 24 h at 37°C and were either unfixed
and unpermeabilized, fixed and then permeabilized for 5 min with 0.2%
Triton X-100 at room temperature, or fixed and then permeabilized with 25
g digitonin per milliliter at 0°C. The cells were stained with anti-HA mAb
followed by rhodamine red conjugated anti-mouse Ig and examined by
confocal microscopy. Unstained cells were visualized by differential in-
terference contrast. Bars, 10 m.
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The orientation of the F13L protein on vesicles and IEV
was determined by selective permeabilization of the cellular
plasma membrane with a low concentration of digitonin.
Under these conditions, both the N- and the C-terminal
epitope tags reacted with the HA mAb, indicating their
cytoplasmic location. As a control, we showed that the B5R
membrane protein did not react with a mAb to its luminal
domain under the same conditions, but did react when the
cells were permeabilized with Triton X-100. The N- and
C-termini of the F13L protein were also oriented toward the
cytoplasm when it was expressed by transfection in the
absence of other viral proteins. Under these conditions, the
F13L protein is associated primarily with the Golgi com-
plex, endosomal vesicles, and the plasma membrane (Hu-
sain and Moss, 2001). In infected cells, the presence of the
F13L protein in both the inner and the outer IEV mem-
branes was visualized by immunoelectron microscopy. Fur-
thermore, we could directly demonstrate the epitope-tagged
proteins lining the internal side of the CEV membrane by
electron microscopy, a result that was consistent with pre-
vious determinations of the resistance of the F13L protein-
to-protease digestion and the inability to label intact extra-
cellular virions with a mAb (Roos et al., 1996; Schmutz et
al., 1995). The presence of the F13L protein on the internal
side of the CEV membrane indicated that it must have the
same topology on the inner side of the two IEV membranes.
The locations of the F13L protein on the cytoplasmic side of
the outer IEV membrane and the side of the inner IEV
membrane facing the virion are consistent with the wrap-
ping of IMV by cisternal membranes containing the F13L
protein on their cytoplasmic side, as diagrammed in Fig. 8.
A similar model was suggested by Schmutz and co-workers
(Schmutz et al., 1995).
We used an in vitro transcription–translation system to
explore the mechanism of association of the F13L protein
with cellular membranes. In vitro synthesized F13L protein
could bind to microsomal membranes with the N- and
C-termini facing the exterior, as indicated by their suscep-
tibility to protease digestion. The microsomes increased the
partitioning of the F13L protein into the Triton X-114 de-
tergent phase, suggesting that they catalyzed palymitylation
as occurs posttranslationally in vivo. The ability to extract
the F13L protein with sodium carbonate indicated that the
central hydrophobic domain was not membrane-spanning,
in agreement with our other data. Taken together, these
results indicated that the F13L protein associates peripher-
ally with membranes via the palmitylated regions, as sug-
gested by others (Grosenbach and Hruby, 1998; Grosenbach
et al., 1997; Schmutz et al., 1995). In accord with this idea,
we found that association of the F13L protein with micro-
somal membranes could occur posttranslationally.
In conjunction with other studies (Baek et al., 1997;
Husain and Moss, 2001, 2002; Roper and Moss, 1999; Sung
et al., 1997), we believe that the F13L protein binds periph-
erally to the Golgi complex and through an intrinsic lipase
activity or by activating a cellular lipase, induces the for-
mation of vesicles and cisternae that include additional viral
membrane proteins, and wraps the IMV to form IEV. The
N- and C-terminal cytoplasmic domains of the F13L protein
may have additional undetermined roles in the association
of the cisternal membranes with the IMV, the trafficking of
IEV through the cytoplasm or fusion of the outer IEV
membrane with the plasma membrane.
Materials and methods
Cells and viruses
HeLa, RK-13, and BSC-1 cells were grown and subcul-
tured in Dulbecco’s modified Eagle’s medium (DMEM) and
Eagle’s modified medium (EMEM), respectively, supple-
mented with 10% fetal bovine serum (FBS) and antibiotics
at 37°C with 5% CO2. For virus titrations and analysis of
plaque size, infected BSC-1 monolayers were fixed and
stained with 0.1% crystal violet in 20% ethanol.
Plasmids
F13L polypeptides with an HA epitope tag at the N- or
C-terminus were expressed from plasmid pcDNA3 (Invitro-
gen) under bacteriophage T7 or cytomegalovirus promotors.
An HA epitope sequence was attached to F13L ORF at the
N- or C-terminus by PCR. The PCR fragments were cloned
into plasmid pcDNA3 to form recombinant plasmids
pF13L-HAN and pF13L-HAC. Plasmid pGF13L-HAN and
pGF13L-HAC were generated by replacing the F13L-GFP
fragment with F13L-HAN and F13L-HAC coding sequences
in plasmid pGF13L (Husain and Moss, 2001).
Fig. 8. Diagrammatic representation of the topology of the F13L protein in
cellular and viral membranes.
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Construction of recombinant vaccinia viruses
Recombinant vaccinia viruses expressing F13L-HAN and
F13L-HAC polypeptides were constructed as described ear-
lier (Husain and Moss, 2001). Briefly, HeLa cells were
infected with a vaccinia virus F13L deletion mutant (Blasco
and Moss, 1991) and then transfected with either pGF13L-
HAN or pGF13L-HAC. After 3 days of incubation at 37°C,
cells were harvested and lysates were used to infect BSC-1
cells. Large recombinant plaques were picked and purified
by three rounds of infection of BSC-1 cells. The presence of
the correct F13L fragment in the genome of each recombi-
nant virus was confirmed by PCR.
Transfection and infection
Plasmids used for transfection were prepared with the
Qiagen plasmid preparation kit. HeLa cells were transfected
using Lipofectamine (LF) 2000 (Invitrogen) according to
the manufacturer. Briefly, cells were grown on glass cover-
slips until they were 80% confluent. LF 2000 and DNA
were diluted separately in Opti-MEM I medium (Invitro-
gen), mixed, and incubated at room temperature for 20 min.
The complex of LF 2000 and DNA was added to the cells
for 5 h at 37°C and replaced with fresh medium with 10%
FBS and incubations were continued until 24 h. For infec-
tion, virus stocks were diluted to the appropriate multiplic-
ity in culture medium with 2.5% FBS and added to cell
monolayers in wells or coverslips. After 2 h of incubation at
37°C, the virus inoculum was replaced with fresh culture
medium (2.5% FBS) and incubated for a further 18 to 20 h.
Western blotting
Infected cells were harvested and washed once with
phosphate-buffered saline (PBS). Cells were directly resus-
pended in RIPA buffer (50 mM Tris–HCI, pH 7.5; 150 mM
NaCl; 1% Triton X-100; 0.2% SDS; 1% sodium deoxy-
cholate), vortexed briefly, and incubated on ice for 15 min.
The lysates were centrifuged at 16,000 g for 15 min at 4°C.
The supernatant was collected, reduced, and denatured with
SDS and analyzed by electrophoresis on a 12% polyacryl-
amide gel. Proteins were transferred to a nitrocellulose
membrane and incubated overnight in PBS with 5% milk at
4°C. The membrane was then washed with PBS three times
and incubated with anti-HA mAb (HA.11) diluted 1 to 1000
in 5% milk–PBS for 1 h. After washing the membrane four
times with PBS-T (PBS containing 0.1% Tween 20) the
membrane was incubated as above with horseradish perox-
idase conjugated anti-mouse secondary antibody diluted 1
to 2000. The membrane was washed as above and proteins
were visualized by Super signal chemiluminescence sub-
strate (Pierce).
Confocal and electron microscopy
Transfected or infected cells were fixed with cold 4%
paraformaldehyde in PBS at room temperature for 20 min.
Fixed cells were permeabilized for 5 min with PBS con-
taining either 0.2% Triton X-100 at room temperature or 25
g of digitonin per milliliter at 0°C. Permeabilized cells
were incubated with primary antibodies diluted in 10% FBS
for 1 h followed by secondary antibody diluted in 10% FBS
for 30 min at room temperature. For double staining, cells
were stained separately with each antibody. Stained cells
were washed extensively with PBS and coverslips were
mounted in 20% glycerol. Fluorescence in the cells was
examined under a Leica TCS NT inverted confocal micro-
scope and images were overlaid using Adobe Photoshop
version 5.0.2.
Procedures for immunostaining and electron microscopy
were similar to those previously described (da Fonseca et
al., 2000) except immunostaining was carried out prior to
fixation or cryosectioning where indicated.
In vitro transcription–translation
Polypeptides were synthesized in vitro using the reticu-
locyte TNT quick-coupled transcription–translation system
(Promega) according to the manufacturer’s protocol.
Briefly, 0.5 g of plasmid and [35S]methionine (final con-
centration of 20 Ci/ml) were added to 20 l of TNT
mixture, and the mixture was incubated at 30°C for 90 min.
When indicated, 2 l of canine pancreatic microsomal
membranes (Promega) was added. At the conclusion of the
reaction, the mixture was layered over 0.5 M sucrose and
centrifuged at 16,000 g for 20 min at room temperature. The
supernatant at the top was removed and the membrane pellet
was resuspended directly in SDS–sample buffer or in NTE
buffer (100 mM NaCl; 10 mM Tris–HCl, pH 7.5; 1 mM
EDTA). Polypeptides were resolved on a 4 to 20% or 12%
polyacrylamide SDS gel and detected by autoradiography.
To investigate posttranslational association of polypep-
tides with microsomes, protein synthesis was stopped at 60
min by adding 200 g of cycloheximide per milliliter. After
addition of 2 l of microsomes, the incubation was contin-
ued for 30 min.
Pronase and sodium carbonate treatments
Proteins were synthesized in vitro in the presence or
absence of microsomes and the latter were purified through
a sucrose cushion and resuspended in NTE buffer. Pronase
(0.05 units, Sigma) was added to the protein suspension and
incubated at 0°C for 30 min. The protease action was
stopped by adding 1 l of protease inhibitor cocktail (Sigma).
For sodium carbonate treatment, proteins were synthe-
sized in vitro in the presence of microsomes. The reaction
mixture was centrifuged at 16,000 g for 20 min at room
temperature. The membrane pellet was resuspended gently
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in NTE buffer or 0.1 M sodium carbonate, pH 11.0 and
incubated at 0°C for 20 min. Membranes were purified
through a sucrose cushion as above and the proteins were
resolved by SDS–PAGE and detected by autoradiography.
Triton X-114 extraction
Protein was synthesized in vitro with or without micro-
somes and the reaction mixture was extracted with buffer
containing 1% Triton X-114 for 5 min on ice as previously
described (Bordier, 1981). Proteins in the resulting aqueous
and detergent phases were resolved by SDS–PAGE and
detected by autoradiography.
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